F Dx Advisors, Inc. Abb Vie Inc. Transaction History

F Dx Advisors, Inc.

$659 Million
Q1 2024

A detailed history of F Dx Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, F Dx Advisors, Inc. holds 27,598 shares of ABBV stock, worth $4.73 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

27,598

Previous 36,174 23.71%

Holding current value

$4.73 Million

Previous $5.61 Million 10.35%

% of portfolio

0.76%

Previous 0.43%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $1.37 Million - $1.56 Million	-8,576 Reduced 23.71%	27,598 $5.03 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $1.57 Million - $1.77 Million	-11,397 Reduced 23.96%	36,174 $5.61 Million
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $4.19 Million - $4.85 Million	-31,387 Reduced 39.75%	47,571 $7.09 Million
Q2 2023 Jul 17, 2023	SELL	$132.51 - $164.9 $1.3 Million - $1.62 Million	-9,808 Reduced 11.05%	78,958 $10.6 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $1.83 Million - $2.19 Million	13,224 Added 17.51%	88,766 $14.3 Million

Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $1.1 Million - $1.26 Million	-8,184 Reduced 9.77%	75,542 $10.1 Million
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $330,012 - $419,554	-2,398 Reduced 2.78%	83,726 $12.8 Million
Q1 2022 May 03, 2022	SELL	$131.98 - $163.75 $4.02 Million - $4.99 Million	-30,494 Reduced 26.15%	86,124 $14 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $537,687 - $680,329	5,005 Added 4.48%	116,618 $15.8 Million
Q3 2021 Oct 08, 2021	BUY	$106.4 - $120.78 $71,075 - $80,681	668 Added 0.6%	111,613 $12 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $1.79 Million - $2 Million	17,042 Added 18.15%	110,945 $12.5 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $8.57 Million - $9.43 Million	83,741 Added 824.06%	93,903 $10.2 Million
Q1 2021 Apr 13, 2021	SELL	$102.3 - $112.62 $7.95 Million - $8.75 Million	-77,696 Reduced 88.43%	10,162 $1.1 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $689,477 - $930,867	8,566 Added 10.8%	87,858 $9.41 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $1.06 Million - $1.25 Million	12,389 Added 18.52%	79,292 $6.95 Million
Q2 2020 Jul 22, 2020	BUY	$73.37 - $98.18 $2.03 Million - $2.71 Million	27,642 Added 70.41%	66,903 $6.57 Million
Q1 2020 May 22, 2020	BUY	$64.5 - $97.79 $2.53 Million - $3.84 Million	39,261 New	39,261 $2.99 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $1.19 Million - $1.8 Million	-18,423 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $519,913 - $650,522	-7,208 Reduced 28.12%	18,423 $1.63 Million
Q3 2019 Nov 07, 2019	SELL	$62.98 - $75.72 $1.33 Million - $1.6 Million	-21,192 Reduced 45.26%	25,631 $1.94 Million
Q2 2019 Jul 19, 2019	SELL	$65.7 - $83.98 $360,561 - $460,882	-5,488 Reduced 10.49%	46,823 $3.41 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $798,784 - $940,130	10,355 Added 24.68%	52,311 $4.22 Million
Q4 2018 Apr 29, 2019	SELL	$77.85 - $96.01 $27.3 Million - $33.6 Million	-350,200 Reduced 89.3%	41,956 $3.87 Million
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $25.4 Million - $31.3 Million	326,475 Added 497.06%	392,156 $36.2 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $47,922 - $53,274	-539 Reduced 0.81%	65,681 $6.21 Million
Q2 2018 Aug 08, 2018	SELL	$89.78 - $106.23 $740,415 - $876,078	-8,247 Reduced 11.07%	66,220 $6.14 Million
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $1.1 Million - $1.47 Million	-11,966 Reduced 13.84%	74,467 $7.05 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $4.29 Million - $4.71 Million	-47,953 Reduced 35.68%	86,433 $8.36 Million
Q3 2017 Nov 03, 2017	SELL	$69.85 - $89.22 $597,496 - $763,187	-8,554 Reduced 5.98%	134,386 $11.9 Million
Q2 2017 Aug 11, 2017	BUY	N/A	142,940	142,940 $10.4 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account